Oral microbiome–metabolome axis links glycerophospholipid dysregulation to Alzheimer’s disease
Tongue biofilm represents a non-invasive, cost-effective, and accessible biomarker source, offering potential for AD diagnosis and research when coupled with microbiome and metabolomic analyses.